What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation? - 100390

Spotlight
Video

What is the Role of Immunotherapy for Patients with Advanced NSCLC and a Driver Mutation?

cancergrace has 1045 videos Subscribe Here

Loading........
Description: Dr. Greg Riely from Memorial Sloan-Kettering Cancer Center reviews the limited data that help clarify the probability of benefit from new immunotherapy agents among patients with advanced NSCLC and an identified driver mutation.

http://cancergrace.org/lung...
Shared By : cancergrace
Posted on : 12/21/15
Added : 3 years ago